angiogenesis inhibitors (Cotinga Pharmaceuticals)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameangiogenesis inhibitors (Cotinga Pharmaceuticals)
Drug Alias Nameangiogenesis inhibitors (Critical Outcome Technologies)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCotinga Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCotinga Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A